Increasing Accessibility of Regenerative Medicine Through Innovative Solutions

通过创新解决方案提高再生医学的可及性

• 批准号: nhmrc : GNT1159277
• 负责人: Dr Rebecca Lim
• 金额: $ 48.34万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Career Development Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/increasing-accessibility-regenerative-innovative-solutions/1349288
• 关键词: Increasing; Accessibility; Regenerative; Medicine; Through

I have established an accessible form of cell therapy that is safe even in premature babies with chronic lung disease. I will extend on my research by working with key industry partners to develop processes for the manufacture of regenerative medicines at a low cost and highly efficient manner. This will expedite patient access to potentially life-saving treatments. These cells will be used in five clinical trials in adults and extremely premature babies across three Australian hospitals.

我已经建立了一种可接受的细胞疗法，即使对患有慢性肺部疾病的早产儿也是安全的。我将通过与关键的行业合作伙伴合作，以低成本和高效率的方式开发生产再生药物的工艺，从而扩大我的研究范围。这将加快患者获得可能挽救生命的治疗的速度。这些细胞将在澳大利亚三家医院的成人和极早产儿身上进行五项临床试验。